Updated: Jan 29
What an onerous year it has been for so many of us, especially for families who have children with neurodevelopmental disabilities. The difficulties we have witnessed in our own children this year only underscore the need for effective treatments for Phelan-McDermid Syndrome.
That’s why we’re excited to announce the launch of CureSHANK’s two signature programs to address the major gap areas in drug development for Phelan-McDermid Syndrome: SHANK3 Therapeutic Accelerator and Trial Ready.
As co-founders of CureSHANK, we are working with the greatest sense of urgency to develop effective treatments not just for future generations of children with Phelan-McDermid Syndrome, but for our own children.
Please show your support by making a donation to CureSHANK: https://cureshank.z2systems.com/.../cureshank/donation.jsp
Thank you and happy holidays! Geraldine, Paulina & Abby